Assignee
GT BIOPHARMA INC
US·0 granted patents·4 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
4 records- 0164US2020000756A1Neostigmine combination and compositionsGT BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 0262US2024425597A1Pd-l1 targeting fusion proteins and methods of use thereofGT BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0361US2025145715A1B7-h3 targeting fusion proteins and methods of use thereofGT BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0442US2019365694A1Composition of matter and use thereof for preventing and treating motion sicknessGT BIOPHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GT BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →